These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12432968)

  • 1. Lack of effect of nizatidine-induced elevation of gastric pH on the oral bioavailability of dapsone in healthy volunteers.
    Itokazu GS; Fischer JH; Manitpisitkul P; Hariharan R; Danziger LH
    Pharmacotherapy; 2002 Nov; 22(11):1420-5. PubMed ID: 12432968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental pharmacokinetics and pharmacodynamics of nizatidine.
    Abdel-Rahman SM; Johnson FK; Connor JD; Staiano A; Dupont C; Tolia V; Winter H; Gauthier-Dubois G; Kearns GL
    J Pediatr Gastroenterol Nutr; 2004 Apr; 38(4):442-51. PubMed ID: 15085026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose pharmacokinetics of nizatidine (Axid) in children.
    Abdel-Rahman SM; Johnson FK; Manowitz N; Holmes GB; Kearns GL
    J Clin Pharmacol; 2002 Oct; 42(10):1089-96. PubMed ID: 12362922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
    Stass H; Böttcher MF; Ochmann K
    Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of dapsone gel, 5% for the treatment of acne vulgaris.
    Thiboutot DM; Willmer J; Sharata H; Halder R; Garrett S
    Clin Pharmacokinet; 2007; 46(8):697-712. PubMed ID: 17655376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of effects of altered gastric pH on absorption of dapsone in healthy volunteers.
    Breen GA; Brocavich JM; Etzel JV; Shah V; Schaefer P; Forlenza S
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2227-9. PubMed ID: 7811056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bioequivalence of nizatidine (Axid) in two extemporaneously and one commercially prepared oral liquid formulations compared with capsule.
    Abdel-Rahman SM; Johnson FK; Gauthier-Dubois G; Weston IE; Kearns GL
    J Clin Pharmacol; 2003 Feb; 43(2):148-53. PubMed ID: 12616667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioequivalence of two oral formulations of nizatidine capsules in healthy male volunteers.
    Lockyer M; Al-Dgither S; Al-Gaai E; Yousuf A; Hammami MM
    Biopharm Drug Dispos; 2005 Apr; 26(3):117-20. PubMed ID: 15723428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early evening nizatidine intake with a meal optimizes the antisecretory effect.
    Duroux P; Emde C; Bauerfeind P; Biollaz J; Armstrong D; Blum AL
    Aliment Pharmacol Ther; 1993 Feb; 7(1):47-54. PubMed ID: 8439637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of food and ranitidine on saquinavir pharmacokinetics and gastric pH in healthy volunteers.
    Kakuda TN; Falcon RW
    Pharmacotherapy; 2006 Aug; 26(8):1060-8. PubMed ID: 16863482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals: omeprazole and ranitidine.
    Kletzl H; Giraudon M; Ducray PS; Abt M; Hamilton M; Lum BL
    Anticancer Drugs; 2015 Jun; 26(5):565-72. PubMed ID: 25643050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of ranitidine and nizatidine in very elderly patients.
    Sasaki M; Sudoh T; Fujimura A
    Am J Ther; 2005; 12(3):223-5. PubMed ID: 15891265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of CYP2D6 by quinidine and its effects on the metabolism of cilostazol.
    Bramer SL; Suri A
    Clin Pharmacokinet; 1999; 37 Suppl 2():41-51. PubMed ID: 10702886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.
    Solans A; Izquierdo I; Donado E; Antonijoan R; Peña J; Nadal T; Carbó ML; Merlos M; Barbanoj M
    Clin Ther; 2008 Sep; 30(9):1639-50. PubMed ID: 18840369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of ranitidine on the pharmacokinetics of rosiglitazone in healthy adult male volunteers.
    Miller AK; DiCicco RA; Freed MI
    Clin Ther; 2002 Jul; 24(7):1062-71. PubMed ID: 12182252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose clinical pharmacokinetic studies of gefitinib.
    Swaisland HC; Smith RP; Laight A; Kerr DJ; Ranson M; Wilder-Smith CH; Duvauchelle T
    Clin Pharmacokinet; 2005; 44(11):1165-77. PubMed ID: 16231967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of promethazine hydrochloride after administration of rectal suppositories and oral syrup to healthy subjects.
    Strenkoski-Nix LC; Ermer J; DeCleene S; Cevallos W; Mayer PR
    Am J Health Syst Pharm; 2000 Aug; 57(16):1499-505. PubMed ID: 10965395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ensure on the oral bioavailability of gatifloxacin in healthy volunteers.
    Kays MB; Overholser BR; Lagvankar S; Goldman M; Sowinski KM
    Pharmacotherapy; 2005 Nov; 25(11):1530-5. PubMed ID: 16232015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of nizatidine on paracetamol and its metabolites in human plasma.
    Itoh H; Nagano T; Takeyama M
    J Pharm Pharmacol; 2002 Jun; 54(6):869-73. PubMed ID: 12079004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.